Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-26-112753
Filing Date
2026-03-18
Accepted
2026-03-18 09:14:56
Documents
1
Effectiveness Date
2026-03-18

Document Format Files

Seq Description Document Type Size
1 15-12G d77910d1512g.htm 15-12G 11022
  Complete submission text file 0001193125-26-112753.txt   12143
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-38997 | Film No.: 26766077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)